机构:
Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USATufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
Kuvin, JT
[1
]
Alsheikh-Ali, AA
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USATufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
Alsheikh-Ali, AA
[1
]
Karas, RH
论文数: 0引用数: 0
h-index: 0
机构:
Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USATufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
Karas, RH
[1
]
机构:
[1] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
There is a distinct inverse relationship between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease risk. HDL-C mediates cholesterol efflux from the vasculature and promotes anti-oxidant, anti-inflammatory, and anti-thrornbotic effects. There are multiple lifestyle and therapeutic interventions that raise HDL-C, and there is increasing evidence that these interventions improve cardiovascular outcomes. Recent findings regarding the role of HDL-C in cholesterol metabolism offer new strategies designed to target atherosclerosis. This review highlights the utility of existing HDL-C-raising strategies and examines new potential therapies.
机构:
Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R ChinaChinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China